Infectious vaginitis, cervicitis, and pelvic inflammatory disease
S Shroff - Medical Clinics, 2023 - medical.theclinics.com
Vaginal symptoms are one of the most common reasons women consult with physicians and
can significantly impact quality of life. 1, 2 Differential diagnosis of vaginal discharge …
can significantly impact quality of life. 1, 2 Differential diagnosis of vaginal discharge …
[HTML][HTML] European cancer mortality predictions for the year 2022 with focus on ovarian cancer
Background Cancer mortality rates, though not absolute numbers of deaths, have been
decreasing over the last three decades in Europe. Materials and methods We estimated …
decreasing over the last three decades in Europe. Materials and methods We estimated …
Lymphatic vasculature in ovarian cancer
Ovarian cancer (OVCA) is the second most common gynecological cancer and one of the
leading causes of cancer related mortality among women. Recent studies suggest that …
leading causes of cancer related mortality among women. Recent studies suggest that …
Ovarian, uterine, and vulvovaginal cancers: screening, treatment overview, and prognosis
DG Kwolek, S Gerstberger, S Tait, JM Qiu - Medical Clinics, 2023 - medical.theclinics.com
Gynecologic cancers, uterine, ovarian, and vulvovaginal, affect approximately 96,000
women and result in approximately 29,000 deaths in the United States annually. In 2022, it …
women and result in approximately 29,000 deaths in the United States annually. In 2022, it …
Recent advancements of antiangiogenic combination therapies in ovarian cancer
D An, S Banerjee, JM Lee - Cancer treatment reviews, 2021 - Elsevier
Ovarian cancer is a deadly malignancy with a growing therapeutic armamentarium, though
achieving sustained benefit in the clinic remains largely elusive. Through biomarker and …
achieving sustained benefit in the clinic remains largely elusive. Through biomarker and …
[HTML][HTML] Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of …
VL Beesley, TL Ross, MT King, R Campbell… - Gynecologic …, 2022 - Elsevier
Objectives Knowledge on the course of symptoms patients with ovarian cancer experience
is limited. We documented the prevalence and trajectories of symptoms after first-line …
is limited. We documented the prevalence and trajectories of symptoms after first-line …
[HTML][HTML] Lipid regulatory proteins as potential therapeutic targets for ovarian cancer in obese women
J Yang, MS Stack - Cancers, 2020 - mdpi.com
Simple Summary Obesity is a recognized epidemic worldwide. Ovarian cancer (OvCa), the
most lethal gynecologic malignancy, is characterized by widely disseminated metastatic …
most lethal gynecologic malignancy, is characterized by widely disseminated metastatic …
Impact of COVID-19 pandemic on ovarian cancer management: adjusting to the new normal
LS Jacome, SK Deshmukh… - Cancer Management …, 2021 - Taylor & Francis
COVID-19, also known as the coronavirus disease 2019, is caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) declared pandemic by the World Health …
respiratory syndrome coronavirus 2 (SARS-CoV-2) declared pandemic by the World Health …
[HTML][HTML] Drugs targeting tumor-initiating cells prolong survival in a post-surgery, post-chemotherapy ovarian cancer relapse model
Disease recurrence is the major cause of morbidity and mortality of ovarian cancer (OC). In
terms of maintenance therapies after platinum-based chemotherapy, PARP inhibitors …
terms of maintenance therapies after platinum-based chemotherapy, PARP inhibitors …
[HTML][HTML] What's in a name? Redefining type 2 diabetes remission
S Kalra, A Singal, T Lathia - Diabetes Therapy, 2021 - Springer
Diabetes remission is a concept that is marked by ample attention, but lack of unanimity.
This opinion piece explores existing definitions of diabetes remission and proposes a …
This opinion piece explores existing definitions of diabetes remission and proposes a …